Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.44 USD | -1.03% | -4.16% | -28.05% |
09/04 | UBS Adjusts Denali Therapeutics Price Target to $32 From $70, Maintains Buy Rating | MT |
03/04 | Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing | MT |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.